Home › Funds › UBS Group AG › PHASQ

UBS Group AG position in PHASQ

PHASEBIO PHARMACEUTICALS INC

Latest position (Q2 2022)9.83K sh
Reported value held$6.00K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd

Quarter by quarter

QuarterSharesValueChange
Q3 2021 1.00K $3.00K New
Q4 2021 4.60K $12.00K Add
Q1 2022 1.58K $2.00K Reduce
Q2 2022 9.83K $6.00K Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding PHASQ

No other tracked fund reports a position in PHASQ.

All PHASQ fund holders →